Boothbay Fund Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $161,242 - $293,952	-2,885 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $208,700 - $274,334	2,885 New	2,885 $244,000
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $199,165 - $266,960	-2,542 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $7,581 - $10,732	78 Added 3.17%	2,542 $248,000
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $12,916 - $14,898	119 Added 5.07%	2,464 $288,000
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $1.69 Million - $2.1 Million	-16,890 Reduced 87.81%	2,345 $278,000
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $251,824 - $526,473	-4,188 Reduced 17.88%	19,235 $2.18 Million
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $534,080 - $747,920	8,000 Added 51.87%	23,423 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $443,818 - $624,021	5,266 Added 51.85%	15,423 $1.41 Million
Q3 2019 Nov 14, 2019	SELL	$84.4 - $106.53 $74,440 - $93,959	-882 Reduced 7.99%	10,157 $876,000
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $112,910 - $176,557	1,239 Added 12.64%	11,039 $1.16 Million
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $1.01 Million - $1.41 Million	9,800 New	9,800 $1.23 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $4.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.